Squamous Cell Carcinoma of the Skin Clinical Trials

26 clinical trials for Squamous Cell Carcinoma of the Skin across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma — RECRUITING · PHASE1
• The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark. — RECRUITING
• Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy — RECRUITING
• Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin — RECRUITING · PHASE2
• Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology — ACTIVE_NOT_RECRUITING
• CivaDerm(TM) Surface Therapy Pilot Study — COMPLETED · PHASE1
• Intratumoral PH-762 for Cutaneous Carcinoma — ACTIVE_NOT_RECRUITING · PHASE1
• Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region — COMPLETED
• The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy — TERMINATED · PHASE2
• SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas — COMPLETED · PHASE1
• How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes — TERMINATED
• Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer — COMPLETED · NA
• Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma — OTHER · PHASE2
• Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin — OTHER · NA
• Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy — OTHER
• Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC — OTHER · PHASE1
• Preventing Squamous Cell Skin Cancer — COMPLETED · PHASE2
• Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer — COMPLETED · PHASE2
• Elucid Labs AIDA™ - Labelled Image Acquisition Protocol — OTHER · NA
• Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin — TERMINATED · PHASE2
• Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) — TERMINATED · PHASE2
• Investigation of Desmoplastic Squamous Cell Carcinoma — OTHER · NA
• T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant — COMPLETED · PHASE2
• Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma — WITHDRAWN · NA
• Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia — COMPLETED · PHASE2
• Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) — WITHDRAWN · PHASE1

Refine this search